PolyPeptide Group AG (LON:0AAJ)
London · Delayed Price · Currency is GBP · Price in CHF 25.08
-0.53 (-2.07%)
Dec 19, 2025, 12:28 PM BST
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 796.2 million as of December 19, 2025. Its market cap has decreased by -5.22% in one year.
Market Cap
796.20M
Enterprise Value
826.63M
Revenue
316.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.08
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.04B to 796.20M, a decrease of -60.96%. That is a compound annual growth rate of -18.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 796.20M | -3.53% |
| Dec 30, 2024 | 825.31M | 53.37% |
| Dec 29, 2023 | 538.12M | -28.11% |
| Dec 30, 2022 | 748.55M | -79.59% |
| Dec 30, 2021 | 3.67B | 79.84% |
| Apr 29, 2021 | 2.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.19B |
| GSK plc | 73.58B |
| Haleon | 32.37B |
| Smith & Nephew | 10.25B |
| Convatec Group | 4.58B |
| Hikma Pharmaceuticals | 3.35B |
| HUTCHMED (China) | 1.74B |
| Genus | 1.70B |